These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17498557)
1. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population. Yin J; Vogel U; Ma Y; Qi R; Sun Z; Wang H Cancer Genet Cytogenet; 2007 May; 175(1):47-51. PubMed ID: 17498557 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population. Yin J; Vogel U; Ma Y; Guo L; Wang H; Qi R Cancer Genet Cytogenet; 2006 Aug; 169(1):27-32. PubMed ID: 16875933 [TBL] [Abstract][Full Text] [Related]
3. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies. Zhan P; Wang Q; Wei SZ; Wang J; Qian Q; Yu LK; Song Y J Thorac Oncol; 2010 Sep; 5(9):1337-45. PubMed ID: 20651612 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung. Lee MS; Liu CY; Su L; Christiani DC Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis. Ma Q; Qi C; Tie C; Guo Z Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma. Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223 [TBL] [Abstract][Full Text] [Related]
7. The polymorphism of DNA repair gene ERCC2/XPD Arg156Arg and susceptibility to breast cancer in a Chinese population. Yin J; Liang D; Vogel U; Chang Y; Liu Z; Yue L; Sun X; Qi R; Song T Biochem Genet; 2009 Aug; 47(7-8):582-90. PubMed ID: 19466538 [TBL] [Abstract][Full Text] [Related]
8. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Liang G; Xing D; Miao X; Tan W; Yu C; Lu W; Lin D Int J Cancer; 2003 Jul; 105(5):669-73. PubMed ID: 12740916 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of DNA repair genes: ERCC1 G19007A and ERCC2/XPD C22541A in a northeastern Chinese population. Yin J; Li J; Vogel U; Wang H Biochem Genet; 2005 Oct; 43(9-10):543-8. PubMed ID: 16341770 [TBL] [Abstract][Full Text] [Related]
10. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing]. Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497 [TBL] [Abstract][Full Text] [Related]
11. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. Xue H; Lu Y; Lin B; Chen J; Tang F; Huang G PLoS One; 2012; 7(9):e43431. PubMed ID: 23028453 [TBL] [Abstract][Full Text] [Related]
12. HapMap-based study of the DNA repair gene ERCC2 and lung cancer susceptibility in a Chinese population. Yin J; Vogel U; Ma Y; Qi R; Wang H Carcinogenesis; 2009 Jul; 30(7):1181-5. PubMed ID: 19406934 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Xing D; Tan W; Wei Q; Lin D Lung Cancer; 2002 Nov; 38(2):123-9. PubMed ID: 12399122 [TBL] [Abstract][Full Text] [Related]
14. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum. Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009 [TBL] [Abstract][Full Text] [Related]
15. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Ni M; Zhang WZ; Qiu JR; Liu F; Li M; Zhang YJ; Liu Q; Bai J Sci Rep; 2014 Feb; 4():4112. PubMed ID: 24531312 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer. Pabalan N; Francisco-Pabalan O; Sung L; Jarjanazi H; Ozcelik H Breast Cancer Res Treat; 2010 Nov; 124(2):531-41. PubMed ID: 20379847 [TBL] [Abstract][Full Text] [Related]
17. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan. Chang WS; Yueh TC; Tsai CW; Ji HX; Wu CN; Wang SC; Lai YL; Hsu SW; Hsieh MH; Hsiao CL; Hung YW; Shih TC; Bau DT Anticancer Res; 2016 Apr; 36(4):1657-63. PubMed ID: 27069143 [TBL] [Abstract][Full Text] [Related]
18. Excision repair cross-complementing group 2/Xeroderma pigmentousm complementation group D (ERCC2/XPD) genetic variations and susceptibility to diffuse large B cell lymphoma in Egypt. El-Din MA; Khorshied MM; El-Saadany ZA; El-Banna MA; Reda Khorshid OM Int J Hematol; 2013 Dec; 98(6):681-6. PubMed ID: 24258710 [TBL] [Abstract][Full Text] [Related]
19. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis. Lu X; Xiao S; Jin C; van der Straaten T; Li X J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529 [TBL] [Abstract][Full Text] [Related]
20. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis. Peng Q; Li S; Lao X; Chen Z; Li R; Qin X Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]